Effect of Xiaoxuming Decoction on activation of astrocytes in acute cerebral ischemia/reperfusion injury.
10.19540/j.cnki.cjcmm.20230706.401
- Author:
Xue-Qin FU
1
;
Man-Man WANG
1
;
Rui LAN
2
;
Yong ZHANG
3
;
Xu-Huan ZOU
1
;
Wei-Wei WANG
1
;
Chen TANG
1
;
Shuang LIU
1
;
Hong-Yu LI
1
Author Information
1. Henan University of Chinese Medicine Zhengzhou 450000, China.
2. the First Affiliated Hospital of Henan University of Chinese Medicine Zhengzhou 450000, China.
3. the Third Affiliated Hospital of Zhengzhou University Zhengzhou 450000, China.
- Publication Type:Journal Article
- Keywords:
Xiaoxuming Decoction;
activation of astrocytes;
cerebral ischemia/reperfusion;
glial fibrillary acidic protein(GFAP);
thrombospondin 1(TSP1)
- MeSH:
Rats;
Animals;
Astrocytes;
Brain Ischemia/metabolism*;
Brain;
Reperfusion Injury/metabolism*;
Infarction, Middle Cerebral Artery
- From:
China Journal of Chinese Materia Medica
2023;48(21):5830-5837
- CountryChina
- Language:Chinese
-
Abstract:
This study investigated the effect of Xiaoxuming Decoction(XXMD) on the activation of astrocytes after cerebral ischemia/reperfusion(I/R) injury. The model of cerebral IR injury was established using the middle cerebral artery occlusion method. Fluorocitrate(FC), an inhibitor of astrocyte activation, was applied to inhibit astrocyte activation. Rats were randomly divided into a sham group, a model group, a XXMD group, a XXMD+FC group, and a XXMD+Vehicle group. Neurobehavioral changes at 24 hours after cerebral IR injury, cerebral infarction, histopathological changes observed through HE staining, submicroscopic structure of astrocytes observed through transmission electron microscopy, fluorescence intensity of glial fibrillary acidic protein(GFAP) and thrombospondin 1(TSP1) measured through immunofluorescence, and expression of GFAP and TSP1 in brain tissue measured through Western blot were evaluated in rats from each group. The experimental results showed that neurobehavioral scores and cerebral infarct area significantly increased in the model group. The XXMD group, the XXMD+FC group, and the XXMD+Vehicle group all alleviated neurobehavioral changes in rats. The pathological changes in the brain were evident in the model group, while the XXMD group, the XXMD+FC group, and the XXMD+Vehicle group exhibited milder cerebral IR injury in rats. The submicroscopic structure of astrocytes in the model group showed significant swelling, whereas the XXMD group, the XXMD+FC group, and XXMD+Vehicle group protected the submicroscopic structure of astrocytes. The fluorescence intensity and protein expression of GFAP and TSP1 increased in the model group compared with those in the sham group. However, the XXMD group, the XXMD+FC group, and XXMD+Vehicle group all down-regulated the expression of GFAP and TSP1. The combination of XXMD and FC showed a more pronounced effect. These results indicate that XXMD can improve cerebral IR injury, possibly by inhibiting astrocyte activation and down-regulating the expression of GFAP and TSP1.
